SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-127830
Filing Date
2022-04-28
Accepted
2022-04-28 16:52:39
Documents
4
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d467396ddef14a.htm DEF 14A 355798
2 GRAPHIC g467396g01t71.jpg GRAPHIC 185692
3 GRAPHIC g467396g02t72.jpg GRAPHIC 103899
4 GRAPHIC g467396g07q71.jpg GRAPHIC 44508
  Complete submission text file 0001193125-22-127830.txt   801235
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39756 | Film No.: 22867625
SIC: 2834 Pharmaceutical Preparations